SCHEMBL6419867

SCHEMBL6419867

O=C(Nc1ccc(NC(=O)c2ccccc2)c2c1C(=O)c1ccccc1C2=O)c1ccccc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.82
▸ KMT2A Q03164 5/20 0.82
▸ MMP14 P50281 1/20 0.82
▸ CYP1A2 P05177 1/20 0.72
▸ TSHR P16473 1/20 0.72
▸ CASP3 P42574 1/20 0.61
▸ POLB P06746 4/20 0.59
▸ BLM P54132 2/20 0.59
▸ RXFP1 Q9HBX9 2/20 0.59
▸ CCR6 P51684 2/20 0.59
▸ HSP90AA1 P07900 3/20 0.57
▸ HSP90AB1 P08238 3/20 0.57
▸ HKDC1 Q2TB90 2/20 0.57
▸ ACE2 Q9BYF1 1/20 0.57
▸ TDP2 O95551 1/20 0.57
▸ G6PD P11413 1/20 0.57
▸ PAX8 Q06710 1/20 0.57
▸ HDAC6 Q9UBN7 1/20 0.57
▸ TP53 P04637 2/20 0.56
▸ MDM4 O15151 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544874 1.00 MEN1 (0.82) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL9174800 0.95 MEN1 (0.76) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL14600815 0.95 MEN1 (0.76) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL12957175 0.95 MEN1 (0.76) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL3415157 0.92 MEN1 (0.72) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL1984615 0.91 MEN1 (0.70) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL10796638 0.91 CYP1A2 (0.78) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL7034212 0.91 MEN1 (0.70) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL30546483 0.91 MEN1 (0.70) MEN1KMT2AMMP14CYP1A2TSHR
SCHEMBL6141826 0.91 MEN1 (1.00) MEN1KMT2AMMP14CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0557121-B1 Polymer scale preventive agent SHINETSU CHEMICAL CO (JP) 1996-11-27 — — EP claimed
US-20070271712-A1 Process for Dyeing Cellulosic Fibre Materials With at Least Two Vat Dyes HUNTSMAN INTERNATIONAL LLC 2007-11-29 — — US disclosed
US-20070271712-A1 Process for Dyeing Cellulosic Fibre Materials With at Least Two Vat Dyes HUNTSMAN INTERNATIONAL LLC 2007-11-29 — — US disclosed
US-20070214581-A1 Method of Dyeing or Printing Cellulosic Fibre Materials With Vattable Dyes HUNTSMAN INTERNATIONAL LLC. (US) 2007-09-20 — — US disclosed
US-20070214581-A1 Method of Dyeing or Printing Cellulosic Fibre Materials With Vattable Dyes HUNTSMAN INTERNATIONAL LLC. (US) 2007-09-20 — — US disclosed
US-20070000076-A1 Process for printing or dyeing cellulose/polyester mixed fibres HUNTSMAN INTERNATIONAL LLC 2007-01-04 — — US disclosed
US-20070000076-A1 Process for printing or dyeing cellulose/polyester mixed fibres HUNTSMAN INTERNATIONAL LLC 2007-01-04 — — US disclosed
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 — — US disclosed
US-20030082101-A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species CAVALIER DISCOVERY 2003-05-01 — — US disclosed
EP-0557121-B1 Polymer scale preventive agent SHINETSU CHEMICAL CO (JP) 1996-11-27 — — EP disclosed
US-5352748-A Coating of antraquinone dye and reducing agent in alkaline solution; emulsion/suspension/bulk/solution and gas phase polymerization of ethylenically unsaturated compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1994-10-04 — — US disclosed
EP-0557121-A2 Polymer scale preventive agent Shin-Etsu Chemical Co., Ltd. (JP) 1993-08-25 — — EP disclosed
US-4520072-A DISSOLVING A COLORING SUBSTANCE IN SOLVENT AND ABSORPTION ON CARRIER ASAHI-DOW LIMITED (JP) 1985-05-28 — — US disclosed
EP-0025926-B1 PROCESS FOR THE PREPARATION OF MONOAROYLATED 1,4-DIAMINO ANTHRAQUINONES BAYER AG (DE) 1982-11-24 — — EP disclosed
US-4324732-A IN PRESENCE OF TERITIARY ALIPHATIC AMINOALCOHOL AND/OR QUARTERNARY AMMONIUM COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1982-04-13 — — US disclosed
EP-0025926-A1 Process for the preparation of monoaroylated 1,4-diamino anthraquinones BAYER AG (DE) 1981-04-01 — — EP disclosed
US-4165306-A Mass-dyeing of polyester with anthraquinone and benzanthrone dyes SANDOZ LTD. (CH) 1979-08-21 — — US disclosed
US-4153719-A Aromatic diketones STERLING DRUG INC. (US) 1979-05-08 — — US disclosed
US-3969302-A Process for the dyeing of colored shaped articles of high polymer, synthetic resins and preparations for such process CIBA-GEIGY AG (CH) 1976-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082101-A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species SOD1, SOD3, APEX1 MEN1 3202/4885KMT2A 3464/4885MMP14 418/4885
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM MEN1 4402/4885KMT2A 1696/4885MMP14 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback